Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Clinical Immunology · ZNF341 Deficiency

Understanding Your ZNF341 Deficiency Diagnosis

At a Glance

ZNF341 deficiency is a rare inherited cause of Hyper-IgE syndrome. It lowers STAT3 pathway activity, leading to very high IgE, eczema, and recurrent skin or lung infections; care commonly includes infection prevention, skin treatment, and specialist monitoring.

Receiving a diagnosis of ZNF341 deficiency often marks the end of a long and exhausting “diagnostic odyssey.” For many families, this journey involves years of unexplained infections, multiple hospitalizations, and consulting numerous specialists before finding an answer through genetic sequencing [1][2].

It is completely natural to feel a mix of shock, worry, and even a strange sense of relief now that your symptoms have a name [3][4]. Hearing that there are only about 20 reported cases of this condition worldwide in the literature as of 2023 can feel isolating [5]. However, this number will likely change as testing improves, and while the name is rare, much of how the condition behaves is familiar to immunologists because it closely mirrors a more common condition called STAT3-associated Hyper-IgE Syndrome (also known as Job’s Syndrome) [5][6].

What is ZNF341 Deficiency?

ZNF341 deficiency is an autosomal recessive genetic condition, meaning a person must inherit two mutated copies of the affected gene (one from each parent) to develop the disorder [5]. A genetic counselor can help explain what carrier status means for family members and provide guidance for future family planning. It is classified as a type of Hyper-IgE Syndrome (HIES), a group of rare primary immunodeficiencies characterized by very high levels of IgE (an antibody involved in allergic responses) and frequent infections [7][8].

The ZNF341 gene provides instructions for making a protein that acts like a “volume knob” for another vital protein called STAT3 [6]. STAT3 is essential for telling the immune system how to fight off specific bacteria and fungi. When ZNF341 is missing or not working, the body cannot produce enough STAT3, leading to an immune system that is “turned down” when it should be fighting and “turned up” in ways that cause severe allergies and eczema [6][7].

How It Affects the Body

Because ZNF341 deficiency lowers the activity of the STAT3 pathway, it shares many of the core features seen in STAT3-HIES, though research suggests the non-immune features are variable and often milder [5].

Immune System and Infections

  • Recurrent Infections: The most common challenge is frequent infections, particularly in the skin and lungs [7]. These are often caused by bacteria like Staphylococcus aureus or fungi like Candida [9][10].
  • Severe Eczema: Most patients experience significant atopic dermatitis (eczema) that begins early in life [5][11].
  • High IgE Levels: Laboratory tests typically show exceptionally high levels of IgE antibodies and often a high count of eosinophils (a type of white blood cell linked to allergies) [7][8].

Beyond the Immune System

In STAT3-HIES, patients often face significant issues with their bones, teeth, and blood vessels. In ZNF341 deficiency, these “extra-hematopoietic” (outside the blood/immune system) manifestations appear to be variable and incompletely characterized, but are generally less severe [5][6]:

  • Skeletal Health: Some patients may have mild skeletal issues or a higher risk of fractures, though not as frequently as in Job’s Syndrome [7][9].
  • Dental Features: While STAT3-HIES often causes “retained baby teeth” (where primary teeth don’t fall out on their own), this is reported less consistently in ZNF341 deficiency [12][13].

A Roadmap for Care

The rarity of this diagnosis can make it feel like there is no “manual” for your care [5]. However, because the biology so closely overlaps with STAT3-HIES, doctors use the established management strategies for that condition as an extrapolated template for ZNF341 deficiency, adjusting it to your individual symptoms [5][12].

Standard care typically focuses on “proactive protection” rather than just reacting to illness. This includes:

  1. Antimicrobial Prophylaxis: Taking daily low-dose antibiotics or antifungals to prevent skin and lung infections before they start [9][12].
  2. Skin Care: Aggressive treatment of eczema to keep the skin barrier intact, which helps prevent bacteria from entering the body [12].
  3. Immunoglobulin Therapy: In some cases, infusions of antibodies (IVIG or SCIG) are used to help the immune system recognize and fight germs more effectively [14][15].
  4. Monitoring: Regular checks of lung function and dental development to catch any issues early [12][16].

Navigating the Emotions of “Ultra-Rare”

It is common for parents to feel they must become the “expert” on their child’s condition because many local doctors may have never heard of it [17]. You may feel a loss of connection with “standard” parenting groups or even common allergy groups [3].

Finding a specialized immunologist who treats Hyper-IgE Syndromes is the most important step in building your support system. While your child’s specific genetic “spelling” is rare, the community of patients living with STAT3-related issues is larger and can offer a wealth of shared experience and support [18]. Your medical team is not starting from scratch; they are applying decades of research from similar conditions to ensure you receive the most informed care possible [12].

Common questions in this guide

What is ZNF341 deficiency?
ZNF341 deficiency is a rare inherited immune disorder and a form of Hyper-IgE syndrome. A person develops it when both copies of the ZNF341 gene have mutations, which reduce STAT3 pathway activity and can lead to very high IgE, eczema, and recurrent infections.
How is ZNF341 deficiency inherited?
ZNF341 deficiency follows an autosomal recessive inheritance pattern, meaning a person must inherit two mutated copies of the gene, one from each parent. Genetic counseling can help relatives understand carrier status and support future family planning.
What health problems are common with ZNF341 deficiency?
People commonly have recurrent skin and lung infections, severe eczema, very high IgE levels, and high eosinophil counts, which involve allergy-related white blood cells. Infections may involve bacteria such as Staphylococcus aureus or fungi such as Candida, while skeletal and dental findings can be more variable.
Is ZNF341 deficiency the same as Job's syndrome?
ZNF341 deficiency is not caused by the same gene as STAT3-associated Hyper-IgE syndrome, also called Job's syndrome. The conditions can look similar because both affect the STAT3 pathway, but bone, tooth, and blood-vessel features may be less severe or less consistent with ZNF341 deficiency.
How is ZNF341 deficiency treated?
Care is individualized and often follows strategies used for STAT3-associated Hyper-IgE syndrome. It may include preventive antibiotics or antifungals, intensive eczema and skin-barrier care, antibody infusions through a vein or under the skin (IVIG or SCIG) for some patients, and regular lung and dental monitoring.
Which specialists should care for someone with ZNF341 deficiency?
Because ZNF341 deficiency is ultra-rare, care is best coordinated with a clinical immunologist familiar with Hyper-IgE syndromes. The team may use knowledge from STAT3-associated cases while tailoring monitoring and treatment to the person's symptoms and genetic variant.

Get notified when new evidence is published on Autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.

    Zurynski Y, Deverell M, Dalkeith T, et al.

    Orphanet journal of rare diseases 2017; (12(1)):68 doi:10.1186/s13023-017-0622-4.

    PMID: 28399928
  2. 2

    Phenotypes of 126 Moroccan HIES patients according to NIH Score.

    Fadil I, Benhsaien I, El Bakkouri J, et al.

    La Tunisie medicale 2024; (102(10)):696-701 doi:10.62438/tunismed.v102i10.5148.

    PMID: 39441153
  3. 3

    Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases.

    Krabbenborg L, Vissers LE, Schieving J, et al.

    Journal of genetic counseling 2016; (25(6)):1207-1214 doi:10.1007/s10897-016-9958-5.

    PMID: 27098417
  4. 4

    Receiving Genomic Sequencing Results through the Victorian Undiagnosed Disease Program: Exploring Parental Experiences.

    Martinussen J, Chalk M, Elliott J, Gallacher L

    Journal of personalized medicine 2022; (12(8)) doi:10.3390/jpm12081250.

    PMID: 36013198
  5. 5

    Inherited human ZNF341 deficiency.

    Béziat V, Fieschi C, Momenilandi M, et al.

    Current opinion in immunology 2023; (82()):102326 doi:10.1016/j.coi.2023.102326.

    PMID: 37080116
  6. 6

    A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.

    Béziat V, Li J, Lin JX, et al.

    Science immunology 2018; (3(24)) doi:10.1126/sciimmunol.aat4956.

    PMID: 29907691
  7. 7

    ZNF341 controls STAT3 expression and thereby immunocompetence.

    Frey-Jakobs S, Hartberger JM, Fliegauf M, et al.

    Science immunology 2018; (3(24)) doi:10.1126/sciimmunol.aat4941.

    PMID: 29907690
  8. 8

    STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases.

    Lorenzini T, Dotta L, Giacomelli M, et al.

    Journal of leukocyte biology 2017; (101(1)):29-38 doi:10.1189/jlb.5RI0516-237RR.

    PMID: 27803128
  9. 9

    Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome.

    Tar I, Szegedi M, Krasuska-Sławińska E, et al.

    Central-European journal of immunology 2023; (48(3)):228-236 doi:10.5114/ceji.2023.130874.

    PMID: 37901871
  10. 10

    STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.

    Tsilifis C, Freeman AF, Gennery AR

    Journal of clinical immunology 2021; (41(5)):864-880 doi:10.1007/s10875-021-01051-1.

    PMID: 33932191
  11. 11

    Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.

    Shamriz O, Rubin L, Simon AJ, et al.

    Frontiers in immunology 2022; (13()):1044933 doi:10.3389/fimmu.2022.1044933.

    PMID: 36605204
  12. 12

    How I Treat: STAT3 hyper IgE syndrome.

    Murray CE, Jannoud E, Prader S, Grimbacher B

    Journal of human immunity 2026; (2(4)):e20260038 doi:10.70962/jhi.20260038.

    PMID: 42221228
  13. 13

    Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential.

    Meixner I, Hagl B, Kröner CI, et al.

    Orphanet journal of rare diseases 2020; (15(1)):244 doi:10.1186/s13023-020-01516-3.

    PMID: 32912316
  14. 14

    Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: Single-center cohort analysis.

    Freeman AF, Wang C, Urban A, et al.

    The Journal of allergy and clinical immunology 2026; (158(2)):569-581 doi:10.1016/j.jaci.2026.04.012.

    PMID: 42061468
  15. 15

    Reduced Immunoglobulin (Ig) G Response to Staphylococcus aureus in STAT3 Hyper-IgE Syndrome.

    Stentzel S, Hagl B, Abel F, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; (64(9)):1279-1282 doi:10.1093/cid/cix140.

    PMID: 28203787
  16. 16

    Lung disease in STAT3 hyper-IgE syndrome requires intense therapy.

    Kröner C, Neumann J, Ley-Zaporozhan J, et al.

    Allergy 2019; (74(9)):1691-1702 doi:10.1111/all.13753.

    PMID: 30793327
  17. 17

    "It is like a jungle gym, and everything is under construction": The parent's perspective of caring for a child with a rare disease.

    Currie G, Szabo J

    Child: care, health and development 2019; (45(1)):96-103 doi:10.1111/cch.12628.

    PMID: 30370696
  18. 18

    Alone in a Crowd? Parents of Children with Rare Diseases' Experiences of Navigating the Healthcare System.

    Baumbusch J, Mayer S, Sloan-Yip I

    Journal of genetic counseling 2018; doi:10.1007/s10897-018-0294-9.

    PMID: 30128673

This page is for informational purposes only and does not constitute medical advice. A clinical immunologist and the rest of your care team should interpret your genetic results and create an individualized monitoring and treatment plan.